Citation Impact
Citing Papers
Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector
2006 StandoutNobel
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
2009
Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
2000
EGFR Antagonists in Cancer Treatment
2008 Standout
ErbB-targeted therapeutic approaches in human cancer
2003
Cooperative Inhibition of Renal Cancer Growth by Anti-Epidermal Growth Factor Receptor Antibody and Protein Kinase A Antisense Oligonucleotide
1998
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Inflammation and cancer
2002 StandoutNature
Epidermal growth factor receptor tyrosine kinase
1994
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Cancer Metastasis: Building a Framework
2006 Standout
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
2001
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Identification and Characterization of the Binding Sites of P-Glycoprotein for Multidrug Resistance-Related Drugs and Modulators
2004
Use of a microbubble agent to increase the effects of high intensity focused ultrasound on liver tissue
2005
Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature
2015
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Stem cells find their niche
2001 StandoutNature
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
The Hallmarks of Cancer
2000 Standout
Tumor targeting with a selective gelatinase inhibitor
1999
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells
2002
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
2004 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
The microenvironment of the tumour–host interface
2001 StandoutNature
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
2005 Standout
Requirement for Specific Proteases in Cancer Cell Intravasation as Revealed by a Novel Semiquantitative PCR-Based Assay
1998
Hematopoietic Stem-Cell Transplantation
2006 Standout
State-of-the-art management of locally advanced head and neck cancer
2005
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
The Biology of Hair Follicles
1999 Standout
Microtubules as a target for anticancer drugs
2004 Standout
Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas
1997
Fibroblasts in cancer
2006 Standout
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Asymmetric Multicomponent Reactions (AMCRs): The New Frontier
2005 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Epidermal Growth Factor Receptor (EGFR) Antibody Down-regulates Mutant Receptors and Inhibits Tumors Expressing EGFR Mutations
2006
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Changing views of the role of matrix metalloproteinases in metastasis
1997
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Heterotypic Signaling between Epithelial Tumor Cells and Fibroblasts in Carcinoma Formation
2001
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
Matrix Metalloproteinases
1999 Standout
Iron-Catalyzed Reactions in Organic Synthesis
2004 Standout
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
2000
Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
2000
Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy
2004 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Characterization of hematopoietic progenitor mobilization in protease-deficient mice
2004
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
2013 Standout
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.
2001
Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.
1995
Monoclonal Antibody Therapy for Cancer
2003
The Expanding Role of Systemic Therapy in Head and Neck Cancer
2004
Phase I and Pharmacologic Study of the Specific Matrix Metalloproteinase Inhibitor BAY 12-9566 on a Protracted Oral Daily Dosing Schedule in Patients With Solid Malignancies
2000
BindingDB Entry 50022536: Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.
2025
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Regulation of Mammalian O2Homeostasis by Hypoxia-Inducible Factor 1
1999 StandoutNobel
Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.
1998
Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia
2002
Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer
2003
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
1999
Angiogenesis and Tumor Metastasis
1998
Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
1998
Plakoglobin Suppresses Epithelial Proliferation and Hair Growth in Vivo
2000 StandoutNobel
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
2004 Standout
Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin
2000
Works of G. Box being referenced
In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance
1999
Treatment of implanted liver tumors with focused ultrasound
1998
Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer
1993
Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction
1993
Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
1994
Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
2000
Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).
1996